They found that terminally exhausted CD8 + T cells were enriched in metastatic disease and showed restricted TCR diversity, with a newly identified bi-directional inhibitory circuit between these exhausted T cells and M2-like macrophages. The gene discussed is CD8A; the disease is metastatic neoplasm.